(Q84403214)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20547309%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

title

Molecular classification of hepatocellular carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20547309%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

main subject

hepatocellular carcinoma

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20547309%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

publication date

1 July 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20547309%20AND%20SRC:MED&resulttype=core&format=json

Digestive and Liver Disease

5 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20547309%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

volume

42 Suppl 3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20547309%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

page(s)

S235-41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20547309%20AND%20SRC:MED&resulttype=core&format=json

Cancer genes and the pathways they control

5 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

Genetics of hepatocellular tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

The Catalogue of Somatic Mutations in Cancer (COSMIC)

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

Bi-allelic inactivation of TCF1 in hepatic adenomas

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

Familial liver adenomatosis associated with hepatocyte nuclear factor 1alpha inactivation

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

Genomics and signaling pathways in hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

Transmembrane control of cadherin-mediated cell adhesion: a 94 kDa protein functionally associated with a specific region of the cytoplasmic domain of E-cadherin

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

Beta-catenin is temporally regulated during normal liver development

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

Morphogenesis of chicken liver: identification of localized growth zones and the role of beta-catenin/Wnt in size regulation

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

Beta-catenin antisense studies in embryonic liver cultures: role in proliferation, apoptosis, and lineage specification

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

Apc tumor suppressor gene is the "zonation-keeper" of mouse liver

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

New targets of beta-catenin signaling in the liver are involved in the glutamine metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

Changes in WNT/beta-catenin pathway during regulated growth in rat liver regeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

Conditional deletion of beta-catenin reveals its role in liver growth and regeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

Beta-catenin mutations in hepatocellular carcinoma correlate with a low rate of loss of heterozygosity.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

Cholestasis is a marker for hepatocellular carcinomas displaying beta-catenin mutations

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

Unique phenotype of hepatocellular cancers with exon-3 mutations in beta-catenin gene.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

Beta-catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

Mutational hot spot in the p53 gene in human hepatocellular carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

Specific association between alcohol intake, high grade of differentiation and 4q34-q35 deletions in hepatocellular carcinomas identified by high resolution allelotyping

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

P53 gene and Wnt signaling in benign neoplasms: beta-catenin mutations in hepatic adenoma but not in focal nodular hyperplasia.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

Frequent mutations of hepatocyte nuclear factor 1 in colorectal cancer with microsatellite instability.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

Mutation of TCF1 encoding hepatocyte nuclear factor 1α in gynecological cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

Germline hepatocyte nuclear factor 1alpha and 1beta mutations in renal cell carcinomas.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

Nuclear beta-catenin staining and absence of steatosis are indicators of hepatocellular adenomas with an increased risk of malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

Genotype–phenotype correlation in hepatocellular adenoma: New classification and relationship with HCC

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

Identification of homozygous deletions at chromosome 16q23 in aflatoxin B1 exposed hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

Gene expression patterns in human liver cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

Molecular profiling of human hepatocellular carcinoma defines mutually exclusive interferon regulation and insulin-like growth factor II overexpression

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

Met-regulated expression signature defines a subset of human hepatocellular carcinomas with poor prognosis and aggressive phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

Focal gains of VEGFA and molecular classification of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

Transforming growth factor-beta gene expression signature in mouse hepatocytes predicts clinical outcome in human cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

Gene expression in fixed tissues and outcome in hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

Transcription and processing of human microRNA precursors

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

Downregulation of miR-122 in the rodent and human hepatocellular carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

Microarray analysis of microRNA expression in hepatocellular carcinoma and non-tumorous tissues without viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

Profiling microRNA expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a microRNA-224-specific target.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

Elevated expression of the miR-17-92 polycistron and miR-21 in hepadnavirus-associated hepatocellular carcinoma contributes to the malignant phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

Identification of metastasis-related microRNAs in hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

MicroRNA expression, survival, and response to interferon in liver cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

Bead-based microarray analysis of microRNA expression in hepatocellular carcinoma: miR-338 is downregulated

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

Beta-catenin mutations are frequent in human hepatocellular carcinomas associated with hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

Close correlation between beta-catenin gene alterations and nuclear accumulation of the protein in human hepatocellular carcinomas.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

beta-Catenin mutation and overexpression in hepatocellular carcinoma: clinicopathologic and prognostic significance.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

Infrequent point mutations in codons 12 and 61 of ras oncogenes in human hepatocellular carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

Low incidence of point mutation of c-Ki-ras and N-ras oncogenes in human hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

Frequent k- ras -2 mutations and p16(INK4A)methylation in hepatocellular carcinomas in workers exposed to vinyl chloride

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

Absence of PIK3CA hotspot mutations in hepatocellular carcinoma in Japanese patients

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

p53 mutation is a poor prognostic indicator for survival in patients with hepatocellular carcinoma undergoing surgical tumour ablation

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

Infrequent alterations of the p16INK4A gene in liver cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

High frequency of p16INK4A gene alterations in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

Genetic alterations of Wnt signaling pathway-associated genes in hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

Mutations of beta-catenin and AXIN I genes are a late event in human hepatocellular carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

Differential effects of inactivated Axin1 and activated beta-catenin mutations in human hepatocellular carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

Smad2 and Smad4 gene mutations in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

PTEN / MMAC1 mutation and frequent loss of heterozygosity identified in chromosome 10q in a subset of hepatocellular carcinomas.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

PTEN/MMAC1 mutations in hepatocellular carcinomas: somatic inactivation of both alleles in tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

PTEN/MMAC1 mutations in hepatocellular carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

M6P/IGF2R tumor suppressor gene mutated in hepatocellular carcinomas in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

Loss of the gene encoding mannose 6-phosphate/insulin-like growth factor II receptor is an early event in liver carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

Genetic analysis of the LKB1/STK11 gene in hepatocellular carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

Association of CYP1B1 Germ Line Mutations with Hepatocyte Nuclear Factor 1 -Mutated Hepatocellular Adenoma

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

Hepatocellular adenoma displaying a HNF1alpha inactivation in a patient with familial adenomatous polyposis coli

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

Loss of hepatocyte nuclear factor 1alpha function in human hepatocellular adenomas leads to aberrant activation of signaling pathways involved in tumorigenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

HNF1alpha inactivation promotes lipogenesis in human hepatocellular adenoma independently of SREBP-1 and carbohydrate-response element-binding protein (ChREBP) activation

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

Hepatocyte nuclear factor-1 alpha gene inactivation: cosegregation between liver adenomatosis and diabetes phenotypes in two maturity-onset diabetes of the young (MODY)3 families.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2810%2960511-7

7 January 2021

10.1016/S1590-8658(10)60511-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20547309%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference